On the recordSeptember 21, 2016
If the FDA is updating its thinking in its regulatory capacity, I would think that finalizing guidance provides more certainty for the industry than having a lingering updated draft guidance.
Source
congress.govIf the FDA is updating its thinking in its regulatory capacity, I would think that finalizing guidance provides more certainty for the industry than having a lingering updated draft guidance.
Hatch emphasizes the importance of finalizing FDA guidance for industry certainty.
Share
More from Orrin Hatch
I want to thank my dear colleague from Iowa. He is one of the greatest Senators I have served with. He is just a wonderful friend and a wonderful Senator. He has worked his tail off the whole time he has been here. I am grateful for his…
I stand by everything I said during my questioning of Mr. Saul, including concerns about budget summary data.